Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allogene Therapeutics (ALLO) Cash from Investing Activities (2019 - 2025)

Allogene Therapeutics (ALLO) has disclosed Cash from Investing Activities for 7 consecutive years, with $33.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 38.81% to $33.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $95.6 million through Dec 2025, up 26.25% year-over-year, with the annual reading at $95.6 million for FY2025, 26.25% up from the prior year.
  • Cash from Investing Activities hit $33.6 million in Q4 2025 for Allogene Therapeutics, up from $11.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $112.9 million in Q1 2023 to a low of -$76.0 million in Q3 2024.
  • Historically, Cash from Investing Activities has averaged $30.2 million across 5 years, with a median of $27.1 million in 2021.
  • Biggest five-year swings in Cash from Investing Activities: soared 745.02% in 2021 and later crashed 237.59% in 2023.
  • Year by year, Cash from Investing Activities stood at $29.2 million in 2021, then surged by 69.56% to $49.6 million in 2022, then soared by 36.02% to $67.5 million in 2023, then dropped by 18.57% to $54.9 million in 2024, then plummeted by 38.81% to $33.6 million in 2025.
  • Business Quant data shows Cash from Investing Activities for ALLO at $33.6 million in Q4 2025, $11.9 million in Q3 2025, and $43.8 million in Q2 2025.